HB3834 — Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

HB3834 — Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date. · Informed CitizenryHouse Bill 3834 establishes an Oklahoma Breakthrough Therapy framework aimed at streamlining the process for developing and conducting clinical trials for promising medications, specifically mentio…Open in Informed Citizenry